Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT03304665 |
Other study ID # |
170181 |
Secondary ID |
17-M-0181 |
Status |
Active, not recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
November 1, 2017 |
Est. completion date |
March 1, 2027 |
Study information
Verified date |
April 12, 2024 |
Source |
National Institutes of Health Clinical Center (CC) |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Objective: To screen and create a list of adult volunteers in good health for participation
in research studies conducted at the National Institutes of Health (NIH) in Bethesda,
Maryland. Develop a normative set of structural and functional brain MRI scans that are
linked to healthy research volunteer characteristics. Maximize scientific impact of data from
volunteers by broadly sharing with other researchers.
Study Population: Adult males and females in general good health who are 18 years of age and
older.
Design: Adult individuals who are interested in participating in NIMH IRP clinical studies as
a healthy research volunteer can directly visit or be directed to visit the study website
where they will first consent electronically and then complete a set of online self-report
measures. Items may include: demographic information, mental health symptoms, disability
status, substance use patterns, handedness and clinical/family history. Individuals who are
flagged based on predetermined responses to survey items will be further screened by a member
of the study clinical team. If found to be ineligible for the study because of a clinically
significant or unstable medical or mental health condition, these individuals will be
referred back to the community and/or given information about NIMH clinical studies for which
they may be eligible. Respondents with no flags or who pass through additional screening will
be scheduled for an in-person assessment. During the outpatient appointment and after
in-person informed consent, participants will receive a brief clinical interview to screen
for current medical and mental conditions, and risk for self-harm. They will complete
assessments of psychological, emotional, physiologic, biological and cognitive functioning.
Participants will undergo a physical exam and be asked to provide blood and urine samples for
routine clinical labs as well as additional blood samples for future secondary analysis that
could include genetic or biomarker assays. Participants can separately consent for an
optional baseline brain magnetic resonance imaging (MRI) scan and an optional
magnetoencephalography (MEG) exam. All consent forms will explicitly inform participants that
if enrolled in the study, their de-identified data will be broadly and publicly shared
through NIH-approved data repositories. Participants in this recruitment and characterization
study will then be placed on a list of healthy research volunteers from which other NIMH IRP
studies may recruit according to the inclusion and exclusion criteria in their respective
IRB-approved protocols.
Outcome Measures: Outcome measures may include demographic data, mental and medical history
and symptoms, results of psychological, emotional, physiologic, biological, and cognitive
testing, physical exam and MRI findings.
...
Description:
Objective: To screen and create a list of adult volunteers in good health for participation
in research studies conducted at the National Institutes of Health (NIH) in Bethesda,
Maryland. Develop a normative set of structural and functional brain MRI scans that are
linked to healthy research volunteer characteristics. Maximize scientific impact of data from
volunteers by broadly sharing with other researchers.
Study Population: Adult males and females in general good health who are 18 years of age and
older.
Design: Adult individuals who are interested in participating in NIMH IRP clinical studies as
a healthy research volunteer can directly visit or be directed to visit the study website
where they will first consent electronically and then complete a set of online self-report
measures. Items may include: demographic information, mental health symptoms, disability
status, substance use patterns, handedness and clinical/family history. Individuals who are
flagged based on predetermined responses to survey items will be further screened by a member
of the study clinical team. If found to be ineligible for the study because of a clinically
significant or unstable medical or mental health condition, these individuals will be
referred back to the community and/or given information about NIMH clinical studies for which
they may be eligible. Respondents with no flags or who pass through additional screening will
be scheduled for an in-person assessment. During the outpatient appointment and after
in-person informed consent, participants will receive a brief clinical interview to screen
for current medical and mental conditions, and risk for self-harm. They will complete
assessments of psychological, emotional, physiologic, biological and cognitive functioning.
Participants will undergo a physical exam and be asked to provide blood and urine samples for
routine clinical labs as well as additional blood samples for future secondary analysis that
could include genetic or biomarker assays. Participants can separately consent for an
optional baseline brain magnetic resonance imaging (MRI) scan and an optional
magnetoencephalography (MEG) exam. All consent forms will explicitly inform participants that
if enrolled in the study, their de-identified data will be broadly and publicly shared
through NIH-approved data repositories. Participants in this recruitment and characterization
study will then be placed on a list of healthy research volunteers from which other NIMH IRP
studies may recruit according to the inclusion and exclusion criteria in their respective
IRB-approved protocols.
Outcome Measures: Outcome measures may include demographic data, mental and medical history
and symptoms, results of psychological, emotional, physiologic, biological, and cognitive
testing, physical exam and MRI findings.